Vericel Corporation (VCEL) financial statements (2020 and earlier)

Company profile

Business Address 64 SIDNEY ST.
CAMBRIDGE, MA 02139
State of Incorp. MI
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7083272315308
Cash and cash equivalents2718272315308
Short-term investments4365     
Receivables28231817118 
Inventory, net of allowances, customer advances and progress billings744312
Inventory744312 
Other current assets3321010
Other undisclosed current assets4      
Total current assets:112113514527418
Noncurrent Assets
Finance lease, right-of-use asset0
Operating lease, right-of-use asset25
Property, plant and equipment 644431
Long-term investments and receivables9      
Long-term investments9      
Intangible assets, net (including goodwill)    33
Intangible assets, net (excluding goodwill)    33 
Restricted cash and investments0      
Other undisclosed noncurrent assets7      
Total noncurrent assets:42644761
TOTAL ASSETS:153119554934489
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1414111111123
Accounts payable6767862
Accrued liabilities8765450
Employee-related liabilities     1 
Debt5     0
Deferred rent credit 1
Asset retirement obligation     0 
Deferred revenue and credits0    
Other liabilities000000 
Other undisclosed current liabilities  121(1)3
Total current liabilities:2015131312125
Noncurrent Liabilities
Long-term debt and lease obligation22  0   
Long-term debt, excluding current maturities   0   
Operating lease, liability22
Liabilities, other than long-term debt0      
Other liabilities0      
Other undisclosed noncurrent liabilities 22200 
Total noncurrent liabilities:2222200 
Other undisclosed liabilities  179   
Total liabilities:4216322412125
Stockholders' equity
Stockholders' equity attributable to parent, including:111102232522364
Common stock490471383330308305253
Treasury stock, value    (3)  
Accumulated other comprehensive income (loss)0(0)00 (0) 
Accumulated deficit(379)(369)(361)(344)  (288)
Warrants and rights outstanding 0 1112
Other undisclosed stockholders' equity attributable to parent   38(283)(270)36
Total stockholders' equity:111102232522364
TOTAL LIABILITIES AND EQUITY:153119554934489

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues11891645451290
Revenue, net645451290
Cost of revenue
(Cost of Goods and Services Sold)
(38)(32)(30)(28)(26)(17) 
Gross profit:8059342625120
Operating expenses(92)(63)(49)(45)(41)(35)(21)
Other undisclosed operating income      0
Operating loss:(11)(4)(15)(19)(17)(24)(21)
Nonoperating income (expense)2(4)(2)(0)045
Investment income, nonoperating2100030
Foreign currency transaction gain (loss), before tax   (0)(0)0 
Other nonoperating income (expense)(0)(2)(0)(0)0(0) 
Interest and debt expense(0)(1)(1)(0)(0)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes0110000
Loss from continuing operations before income taxes:(10)(8)(17)(20)(16)(20)(16)
Income tax benefit    5  
Net loss:(10)(8)(17)(20)(11)(20)(16)
Other undisclosed net loss attributable to parent    (5)  
Net loss attributable to parent:(10)(8)(17)(20)(16)(20)(16)
Preferred stock dividends and other adjustments   (8)(7)(6)(5)
Other undisclosed net income available to common stockholders, basic      5
Net loss available to common stockholders, diluted:(10)(8)(17)(27)(23)(26)(16)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(10)(8)(17)(20)(11)(20)(16)
Comprehensive loss:(10)(8)(17)(20)(11)(20)(16)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)  (5)(0) 
Comprehensive loss, net of tax, attributable to parent:(10)(8)(17)(20)(16)(20)(16)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: